FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
The FDA has recently granted the Breakthrough Therapy designation to FARXIGA, a chronic kidney disease treatment created by AstraZeneca. This designation will allow for a quicker development, which will hopefully…